Financials

	2025 *	2026 *
Net sales	2.82TCr 2.37TCr 2.16TCr 2.07TCr 3.84TCr 2,55000Cr 3.98TCr 25TCr 9.99TCr 1,23200Cr 11TCr 10TCr 4,30400Cr	3.06TCr 2.57TCr 2.35TCr 2.24TCr 4.16TCr 2,76800Cr 4.32TCr 27TCr 11TCr 1,33600Cr 11TCr 11TCr 4,67100Cr
Net income	112.96Cr 95Cr 87Cr 83Cr 153.85Cr 10TCr 159.85Cr 1.01TCr 400.85Cr 4.94TCr 423.62Cr 414.91Cr 17TCr	139.2Cr 117.29Cr 106.98Cr 102.13Cr 189.59Cr 13TCr 196.98Cr 1.24TCr 493.96Cr 6.09TCr 522.03Cr 511.29Cr 21TCr
Net Debt	1.09TCr 920.43Cr 839.52Cr 801.5Cr 1.49TCr 99TCr 1.55TCr 9.76TCr 3.88TCr 48TCr 4.1TCr 4.01TCr 1,67000Cr	966.25Cr 814.16Cr 742.59Cr 708.96Cr 1.32TCr 88TCr 1.37TCr 8.64TCr 3.43TCr 42TCr 3.62TCr 3.55TCr 1,47700Cr

* Estimated data More financial data

Company Profile

Employees

43,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

25/02 - Q4 2025 Earnings Release

More about the company

Quotes

Date	Price	Change	Volume
13/26/13	44.55 $	-0.09%	11,86,727
12/26/12	44.59 $	-1.00%	38,24,644
11/26/11	45.04 $	-0.55%	22,16,712
10/26/10	45.29 $	-4.39%	35,38,583
09/26/09	47.37 $	+0.15%	13,35,213

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

44.55USD

Average target price

47.92USD

Spread / Average Target

+7.57%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
44.55 ^USD	-0.09%		-5.81%	+6.07%

13/02	FDA says Medline identified electrical safety risks with Medline basic homecare beds	RE
06/02	Carlyle allays software fears, private-equity deals boost profit	RE

Capitalization	3.71TCr 3.12TCr 2.85TCr 2.72TCr 5.05TCr 3,35800Cr 5.25TCr 33TCr 13TCr 1,62200Cr 14TCr 14TCr 5,66800Cr	P/E ratio 2025 *	50.9x	P/E ratio 2026 *	41.4x
Enterprise value	4.8TCr 4.04TCr 3.69TCr 3.52TCr 6.54TCr 4,34700Cr 6.79TCr 43TCr 17TCr 2,09900Cr 18TCr 18TCr 7,33700Cr	EV / Sales 2025 *	1.7x	EV / Sales 2026 *	1.53x
Free-Float	-	Yield 2025 *	0.85%	Yield 2026 *	0.58%

13/02	FDA says Medline identified electrical safety risks with Medline basic homecare beds	RE
06/02	Carlyle allays software fears, private-equity deals boost profit	RE
29/01	Nasdaq profit beats estimates; CEO touts IPO pipeline	RE
15/01	Medline Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:00 PM
13/01	JPMorgan profit beats estimates on trading boom, shares hit by weaker investment banking	RE
13/01	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
12/01	Medline Poised to Leverage Business Model to Outsized Performance, RBC Says	MT
12/01	Medline Poised to Sustain High-Single Digit Organic Growth, BofA Says	MT
12/01	Morgan Stanley Initiates Coverage on Medline With Overweight Rating, $48 Price Target	MT
12/01	Leerink Partners Initiates Coverage on Medline With Outperform Rating, $48 Price Target	MT
12/01	Piper Sander Initiates Coverage on Medline With Overweight Rating, $50 Price Target	MT
12/01	Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target	MT
12/01	Jefferies Initiates Coverage on Medline With Buy Rating, $50 Price Target	MT

12/01	Medline Poised to Leverage Business Model to Outsized Performance, RBC Says	MT
12/01	Medline Poised to Sustain High-Single Digit Organic Growth, BofA Says	MT
12/01	Morgan Stanley Initiates Coverage on Medline With Overweight Rating, $48 Price Target	MT
12/01	Leerink Partners Initiates Coverage on Medline With Outperform Rating, $48 Price Target	MT
12/01	Piper Sander Initiates Coverage on Medline With Overweight Rating, $50 Price Target	MT

Medline Inc. Share Price

Equities

MDLN

US58507V1070

Medical Equipment, Supplies & Distribution

Valuation: Medline Inc.

Chart: Medline Inc.

Latest news: Medline Inc.

Last Transcript: Medline Inc.

Analysts' recommendations: Medline Inc.

Press Releases: Medline Inc.

News in other languages: Medline Inc.

Quotes and Performance

Course Extremes

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

19/12	Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	GL
17/12	Medline Announces Pricing of Upsized Initial Public Offering	AQ

15/01	Florierendes Investmentbanking gibt Morgan Stanley Schwung
18/12	Bourse : EssilorLuxottica conserve Burberry, Bernard Arnault rempile pour 10 ans, ça bouge chez BP
18/12	Oracle n'est plus prophète en son pays
18/12	Wall Street : Medline bondit pour sa première cotation, signant la plus grosse IPO depuis quatre ans
17/12	Wall Street : Le rallye des faibles attentes

1 day	-0.09%
1 week	-5.81%
Current month	+0.79%
1 month	+3.97%
Current year	+6.07%

1 week	43.57	47.88
1 month	42.2	47.99
Current year	38.5	47.99
1 year	34.89	47.99
3 years	34.89	47.99
5 years	34.89	47.99
10 years	34.89	47.99

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MEDLINE INC.	-0.09%	-5.81%	-	-	3.71TCr
ABBOTT LABORATORIES	+1.09%	+1.67%	-14.50%	+3.83%	20TCr
MEDTRONIC PLC	-1.38%	-3.31%	+7.91%	+17.89%	13TCr
CENCORA, INC.	+2.96%	+0.44%	+47.56%	+127.50%	7.02TCr
HOYA CORPORATION	-1.12%	+6.41%	+44.01%	+105.40%	6.22TCr
BECTON, DICKINSON AND COMPANY	-1.08%	-16.25%	-21.83%	-28.86%	5.01TCr
DEXCOM, INC.	+7.59%	+0.07%	-16.73%	-40.80%	2.69TCr
STERIS PLC	+1.69%	-1.51%	+13.28%	+26.50%	2.44TCr
TERUMO CORPORATION	-2.87%	-1.69%	-29.22%	+4.39%	1.94TCr
SARTORIUS STEDIM BIOTECH	+4.01%	-1.66%	-18.25%	-49.65%	2.02TCr
Average	+1.08%	+0.16%	+1.36%	+18.47%	6.34TCr
Weighted average by Cap.	+0.61%	+0.52%	+3.50%	+26.34%